Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries
- 1 March 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Menopause
- Vol. 14 (2), 251-260
- https://doi.org/10.1097/01.gme.0000235366.39726.f6
Abstract
Objective: 17β-Estradiol (E2) negatively modulates neointima formation, leukocyte infiltration, and proinflammatory mediator expression after vascular injury in young (10-wk-old) ovariectomized (OVX) rats. Trials of E2 in elderly postmenopausal women have not confirmed a vasoprotective effect. This study tested the hypothesis that responsiveness to E2 is lost in injured arteries of aged (12-mo-old) OVX rats. Design: E2- or vehicle-treated OVX rats underwent balloon injury of the carotid artery and were killed after 2 weeks for morphometric examination of arteries, after 24 hours for assessment of leukocyte infiltration, and after 2 hours for quantification of proinflammatory mediator mRNA expression. Results: Neointima formation was significantly reduced in aged compared with young vehicle-treated rats. E2 treatment had directionally opposite effects on intima/media ratios in aged (+75%) and young (−40%) rats. Injury induced increases in infiltrating total leukocytes, neutrophils, monocytes/macrophages, and expression of proinflammatory mediators in arteries of aged rats; E2 had no effect on these inflammatory responses to injury. Estrogen receptor α and β protein expression were similar in carotid arteries of young and aged rats on immunofluorescence testing. Conclusions: Aged OVX rats lose the vasoprotective and anti-inflammatory responses to exogenous E2 seen in younger animals. These results may be relevant to the lack of vasoprotection observed in outcome trials of estrogen therapy in postmenopausal women.Keywords
This publication has 27 references indexed in Scilit:
- Conjugated Equine Estrogens and Coronary Heart DiseaseArchives of Internal Medicine, 2006
- Hormone Replacement Therapy and InflammationHypertension, 2003
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Estrogen replacement therapy, atherosclerosis, and vascular functionCardiovascular Research, 2002
- A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular DiseaseAnnals of Internal Medicine, 2000
- The Protective Effects of Estrogen on the Cardiovascular SystemNew England Journal of Medicine, 1999
- Medroxyprogesterone Attenuates Estrogen-Mediated Inhibition of Neointima Formation After Balloon Injury of the Rat Carotid ArteryCirculation, 1996
- Estrogen Reduces Myointimal Proliferation After Balloon Injury of Rat Carotid ArteryCirculation, 1996
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal WomenJAMA, 1995
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991